Ernexa Therapeutics Inc (ERNA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Ernexa Therapeutics Inc   (NASDAQ: ERNA)

Ernexa Therapeutics Inc

Officers & Directors


Sanjeev Luther
President, Chief Executive Officer, and Director (Principal Executive Officer)

Sandra Gurrola
Senior Vice President of Finance (Principal Financial Officer and Principal Accounting Officer)

James Bristol
Chairman of the Board

Dorothy Clarke
Director

Peter Cicala
Director

William Wexler
Director

GRANT THORNTON LLP
We have served as the Company s auditor since... ,

Ernexa Therapeutics Inc currently has 5 employees.

  News about Ernexa Therapeutics Inc Key Personnel

Eterna Therapeutics Faces Challenges Amid Leadership Changes and Financial Losses: Can New Vision Propel mRNA Innovation

CAMBRIDGE, Mass.—In a bold move, Eterna Therapeutics Inc. recently announced the appointment of Dr. Elena Ratner, a world-renowned expert in obstetrics and gynecology from Yale University, to its Board of Directors. The company is aiming to leverage Dr. Ratner s extensive experience to enhance its ongoing research in ovarian cancer, a critical area of focus for the biotech firm. However, this promising development comes at a time when Eterna is grappling with significant financial hurdles, raising questions about its future trajectory.In the third quarter of 2024, Eterna recorded a cumulative net loss of $45 million, an alarming figure that translates to a negative return on investment (ROI) of -150.91%. T...






ERNA Management Effectiveness ERNA Revenue per Employee ERNA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.